ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag public health ecology regulation ethics

A close up of a tick held in a pair of forceps, with Kevin Esvelt’s face out of focus in the background.
CRISPR Gene Drives and the Future of Evolution
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.
Science with Borders: Researchers Navigate Red Tape
Max Kozlov | Mar 1, 2021 | 10 min read
Scientists who work with foreign biological specimens face a patchwork of permits that threaten to block their projects, with potentially harmful consequences for the ecosystems they study.
The Regulation Atmosphere
Ted Agres | Mar 4, 2001 | 4 min read
The pharmaceutical industry is cautiously optimistic that the new Bush administration and Congress will continue efforts to streamline the drug discovery and approval process. But the federal regulatory and licensing landscape will also be shaped this year by patent reform and gene therapy issues. In addition, two major pieces of legislation--one affecting drug approval times and the other market exclusivity--will either be phased out or reauthorized in the coming 18 months. "We really c
Close-up shot of sea surface with small waves
The Constellation of Creatures Inhabiting the Ocean Surface
Amanda Heidt | Jan 2, 2023 | 10+ min read
The myriad species floating atop the world’s seas, called neuston, are mysterious and understudied, complicating efforts to clean up plastic pollution.
The Surgisphere Scandal: What Went Wrong?
Catherine Offord | Oct 1, 2020 | 10+ min read
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Notebook
The Scientist Staff | Nov 9, 1997 | 8 min read
Putting the Freeze on Menopause In Defense of Pesticides Pushing Drug Discovery Race and Health Tumor Stopper Jewel of a Specimen Birth of a Journal Conservation Wins GOLDEN EGG: Michael Tucker caused a media stir when he facilitated the birth of twins using frozen eggs. The birth of twins rarely makes national headlines. But this pair, whose birth was announced on the front page of the New York Times on October 17, sparked a flurry of media attention. A team of researchers at Reproductive Bi
Using Gene Drives to Limit the Spread of Malaria
Tony Nolan and Andrea Crisanti | Jan 1, 2017 | 10 min read
Introducing genetic changes into mosquito populations could be key to effective malaria control.
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
MAIL
The Scientist Staff | Feb 1, 2007 | 4 min read
Anthrax, tigers, and bison Jack Woodall has raised some very important and contentious issues in wildlife conservation. 1 It is true that improved funding such as that available in countries like Canada could help achieving conservation goals in developing countries like India, where poaching poses a threat to many wild species, including the tiger. Interestingly, Bandhavgarh Tiger Reserve, where he had an unpleasant and life-threatening experience is supposed to be am

Run a Search

ADVERTISEMENT